中国社区医师2016，Vol.32Issue(27)：26-26,28,2.DOI:10.3969/j.issn.1007-614x.2016.27.13
风湿性心脏病并发心房颤动患者应用胺碘酮治疗的安全性
Safety of amiodarone treatment in patients with rheumatic heart disease combined with atrial fibrillation
摘要
Abstract
Objective:To analyze the treatment effect and safety of amiodarone in patients with rheumatic heart disease combined with atrial fibrillation.Methods:120 patients with rheumatic heart disease combined with atrial fibrillation were selected.They were randomly divided into the control group and the observation group with 60 cases in each.The control group was given conventional treatment.The observation group was given amiodarone treatment.The converting sinus rhythm rate and left atrial diameter of two groups were compared.Results:The converting sinus rhythm rate of the observation group was significantly higher than that of the control group(P=0.011).The left atrial diameter of the observation group was significantly lower than that of the control group(P=0.000).Conclusion:In the treatment of patients with rheumatic heart disease combined with atrial fibrillation,amiodarone can significantly improve the converting sinus rhythm rate,and reduce the left atrial diameter.关键词
胺碘酮/风湿性心脏病/心房颤动/安全性Key words
Amiodarone/Rheumatic heart disease/Atrial fibrillation/Safety引用本文复制引用
吴志英..风湿性心脏病并发心房颤动患者应用胺碘酮治疗的安全性[J].中国社区医师,2016,32(27):26-26,28,2.
